Search research articles
Contact Us
Filters
Showing results (21-30 of 344) with videos related to
Page
of 35
Sort By:
Cancer Cell International
|
February 20, 2009
A reason why the ERBB2 gene is amplified and not mutated in breast cancer
Daniel Birnbaum, Fabrice Sircoulomb, Jean Imbert
The Journal of Pathology
|
March 21, 2012
What drives breast cancer heterogeneity: oncogenic events or cell of origin?
Christophe Ginestier, Emmanuelle Charafe-Jauffret, Daniel Birnbaum
Molecular & Cellular Oncology
|
September 5, 2017
Flick the cancer stem cells' switch to turn cancer off
Christophe Ginestier, Daniel Birnbaum, Emmanuelle Charafe-Jauffret
Oncoscience
|
September 14, 2020
Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations
François Bertucci, Steven Van Laere, Daniel Birnbaum
Breast Cancer Research : BCR
|
October 5, 2010
Targeting breast cancer stem cells: fishing season open!
Christophe Ginestier, Emmanuelle Charafe-Jauffret, Daniel Birnbaum
BMC Cancer
|
June 27, 2009
Breast cancer stem cells: tools and models to rely on
Emmanuelle Charafe-Jauffret, Christophe Ginestier, Daniel Birnbaum
Cell Cycle (Georgetown, Tex.)
|
July 4, 2012
p53 and cancer stem cells: the mevalonate connexion
Christophe Ginestier, Emmanuelle Charafe-Jauffret, Daniel Birnbaum
Cell Cycle (Georgetown, Tex.)
|
January 12, 2010
Cancer stem cells: just sign here!
Emmanuelle Charafe-Jauffret, Christophe Ginestier, Daniel Birnbaum
The New England Journal of Medicine
|
February 4, 2011
Endometriosis-associated ovarian carcinomas
David J Birnbaum, Daniel Birnbaum, François Bertucci
Cell Cycle (Georgetown, Tex.)
|
July 8, 2011
Breast tumor microenvironment: in the eye of the cytokine storm
Christophe Ginestier, Emmanuelle Charafe-Jauffret, Daniel Birnbaum
Page
of 35
Search research articles
Search
Showing results (21-30 of 344) with videos related to
Sort By:
Page
of 35
Cancer Cell International
|
February 20, 2009
A reason why the ERBB2 gene is amplified and not mutated in breast cancer
Daniel Birnbaum, Fabrice Sircoulomb, Jean Imbert
The Journal of Pathology
|
March 21, 2012
What drives breast cancer heterogeneity: oncogenic events or cell of origin?
Christophe Ginestier, Emmanuelle Charafe-Jauffret, Daniel Birnbaum
Molecular & Cellular Oncology
|
September 5, 2017
Flick the cancer stem cells' switch to turn cancer off
Christophe Ginestier, Daniel Birnbaum, Emmanuelle Charafe-Jauffret
Oncoscience
|
September 14, 2020
Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations
François Bertucci, Steven Van Laere, Daniel Birnbaum
Breast Cancer Research : BCR
|
October 5, 2010
Targeting breast cancer stem cells: fishing season open!
Christophe Ginestier, Emmanuelle Charafe-Jauffret, Daniel Birnbaum
BMC Cancer
|
June 27, 2009
Breast cancer stem cells: tools and models to rely on
Emmanuelle Charafe-Jauffret, Christophe Ginestier, Daniel Birnbaum
Cell Cycle (Georgetown, Tex.)
|
July 4, 2012
p53 and cancer stem cells: the mevalonate connexion
Christophe Ginestier, Emmanuelle Charafe-Jauffret, Daniel Birnbaum
Cell Cycle (Georgetown, Tex.)
|
January 12, 2010
Cancer stem cells: just sign here!
Emmanuelle Charafe-Jauffret, Christophe Ginestier, Daniel Birnbaum
The New England Journal of Medicine
|
February 4, 2011
Endometriosis-associated ovarian carcinomas
David J Birnbaum, Daniel Birnbaum, François Bertucci
Cell Cycle (Georgetown, Tex.)
|
July 8, 2011
Breast tumor microenvironment: in the eye of the cytokine storm
Christophe Ginestier, Emmanuelle Charafe-Jauffret, Daniel Birnbaum
Page
of 35